Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$321M |
| 2 |
AABA
Altaba Inc
AABA
|
+$120M |
| 3 |
Amazon
AMZN
|
+$84M |
| 4 |
Dell
DELL
|
+$81.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$58M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.65% |
| 2 | Utilities | 16.59% |
| 3 | Communication Services | 9.1% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Industrials | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EE
51
DELISTED
El Paso Electric Company
EE
| $3.01M | 0.21% |
+60,012
| New | +$3.38M |
|
52
Element Solutions
ESI
$8.6B
| $2.82M | 0.2% |
+273,298
| New | +$3.01M |
|
53
Baxter International
BAX
$13.6B
| $2.78M | 0.2% |
+42,205
| New | +$2.84M |
|
54
KKR & Co
KKR
$97.4B
| $2.47M | 0.17% |
+125,979
| New | +$2.88M |
|
55
Prosperity Bancshares
PB
$8.75B
| $2.41M | 0.17% |
+38,744
| New | +$2.56M |
|
56
Commault Systems
CVLT
$5.55B
| $2.37M | 0.17% |
+40,051
| New | +$2.36M |
|
57
CALL
Madison Square Garden
MSGS
$9.78B
| $2.33M | 0.16% |
+12,197
| New | +$2.37M |
|
58
Portland General Electric
POR
$5.83B
| $2.29M | 0.16% |
+49,925
| New | +$2.34M |
|
59
Johnson & Johnson
JNJ
$651B
| $2.2M | 0.15% |
+17,029
| New | +$2.38M |
|
60
Brady Corp
BRC
$4.3B
| $2.17M | 0.15% |
+49,993
| New | +$2.08M |
|
61
Teva Pharmaceuticals
TEVA
$43.5B
| $2.08M | 0.15% |
+135,144
| New | +$2.77M |
|
62
Regeneron Pharmaceuticals
REGN
$85.9B
| $1.79M | 0.13% |
+4,803
| New | +$1.76M |
|
|
CTRA
63
DELISTED
Coterra Energy
CTRA
| $1.7M | 0.12% |
+75,919
| New | +$1.83M |
|
64
CVS Health
CVS
$119B
| $1.57M | 0.11% |
+24,022
| New | +$1.79M |
|
|
PPL
65
PPL Corp
PPL
$25.9B
| $1.5M | 0.11% |
+52,762
| New | +$1.6M |
|
66
Edwards Lifesciences
EW
$51.8B
| $1.48M | 0.1% |
+28,980
| New | +$1.47M |
|
67
DuPont de Nemours
DD
$18.7B
| $1.47M | 0.1% |
+10,834
| New | +$1.56M |
|
68
Bank OZK
OZK
$5.39B
| $1.43M | 0.1% |
+62,706
| New | +$1.74M |
|
|
EV
69
DELISTED
Eaton Vance Corp.
EV
| $1.43M | 0.1% |
+40,550
| New | +$1.71M |
|
70
Microsoft
MSFT
$3.59T
| $1.34M | 0.09% |
+13,202
| New | +$1.41M |
|
71
American Express
AXP
$227B
| $1.34M | 0.09% |
+14,026
| New | +$1.47M |
|
|
RTN
72
DELISTED
Raytheon Company
RTN
| $1.33M | 0.09% |
+8,644
| New | +$1.55M |
|
73
Nike
NKE
$60.5B
| $1.32M | 0.09% |
+17,844
| New | +$1.33M |
|
74
Kinder Morgan
KMI
$69B
| $1.27M | 0.09% |
+82,924
| New | +$1.4M |
|
75
Alpha Metallurgical Resources
AMR
$2.66B
| $1.24M | 0.09% |
+18,800
| New | +$1.26M |
|
Similar funds
Michael Gelband's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Michael Gelband, which disclosed 334 positions worth $1.42B. Its ten largest holdings account for 60% of the portfolio.
Its largest position is State Street SPDR S&P 500 ETF Trust: 1,189,219 shares worth $297M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Utilities and Communication Services.
- Michael Gelband's largest Q4 2018 buy was State Street SPDR S&P 500 ETF Trust: 1,189,219 shares worth $297M.
- Michael Gelband's ten largest holdings make up 60% of its $1.42B portfolio in Q4 2018.
- Michael Gelband disclosed 334 positions in Q4 2018, its first 13F filing on record.
Based on ExodusPoint Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.